DOCSLIB.ORG

Legal-Graphics' 5-25-21 COVID Timeline

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Legal-Graphics' 5-25-21 COVID Timeline Number of days since first sign of virus Overview: Year 2 of COVID Year 2 Nov. 23, 2020 Dec. 3, 2020 Dec. 11, 2020 Dec. 21, 2020 Dec. 30, 2020 Jan. 7, 2021 Jan.Jan. 14,7, 2021 2021 of COVID-19 Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths over 1,400,000 over 1,500,000 over 1,600,000 over 1,700,000 over 1,800,000 over 1,900,000 over 1,900,0002,000,000 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 Link to Nov. 16, 2020 Nov. 18, 2020 Nov. 21, 2020 Nov. 25, 2020 Nov. 27, 2020 Nov. 30, 2020 Dec. 3, 2020 Dec. 6, 2020 Dec. 8, 2020 Dec. 11, 2020 Dec. 14, 2020 Dec. 17, 2020 Dec. 21, 2020 Dec. 22, 2020 Dec. 26, 2020 Dec. 29, 2020 Dec. 31, 2020 Jan. 3, 2021 Jan. 5, 2021 Jan. 8, 2021 Jan. 11, 2021 Jan. 13, 2021 Jan. 17, 2021 Source Moderna says data FDA allows US cases top Picture of US Demand for live Moderna to request Map showing US UK gears up for Chart of cumulative Pfizer vaccine to be How do the Pfizer Vaccinations reach How the Pfizer Vaccines across Could AZD7442 Map showing How vaccinations Interactive US Map It’s lockdown No. 3 Pfizer vaccine Japan has found Initial Israeli data: Vaccine skepticism shows its vaccine 1st rapid virus test 12 million ... spread economy is Christmas trees emergency states with the huge vaccination number of deaths OK’d in days - and Moderna US nursing homes and Moderna the world prevent COVID-19 which countries were developed by county showing for England, at least appears effective a new Covid variant First Pfizer shot hurts East European Signs of Virus is more than that gives results 'faster' and 'broader' worrisome skyrockets amid authorization their highest number plan watched by country (by “normal” next fall vaccines work? vaccines compare infection have rolled out so quickly risk for COVID six weeks at home against mutation in curbs infections by anti-virus efforts at home as virus toll of virus number of days a COVID-19 vaccine new virus variants 50% after 14 days 94% effective than ever coronavirus vaccine of virus deaths by the world in those exposed? Jan. 11, 2021 Key Events inflicts damage since 100 deaths Dec. 18, 2020 Dec. 22, 2020 Dec. 31, 2020 Jan. 6, 2021 Jan. 17, 2021 Dec. 12, 2020 Dec. 15, 2020 Dec. 21, 2020 Jan. 4, 2021 US vaccine rollout US virus deaths Vaccines across Dec. 30, 2020 Jan. 9, 2021 Jan. 14, 2021 Dec. 1, 2020 Dec. 4, 2020 Dec. 7, 2020 Dec. 27, 2020 Where the world problematic Elderly hunger is Good News! Nov. 17, 2020 Nov. 19, 2020 Nov. 23, 2020 Nov. 28, 2020 Experts to consider and cases set Variant of virus 82 year old EU agency approves Dec. 9, 2020 Tracking nine of the US Nov. 26, 2020 The European Union records spreading across December is the Britain becomes 1st stands on dialysis patient Moderna vaccine US vaccine rollout STUDY: Recovering on the rise Governors ratchet > 900 Mayo Clinic AstraZeneca vaccine United Airlines Job growth China prepares the most promising approving Moderna Legal Matters eyes Dec 29, 2020 UK sending it deadliest month country to approve vaccination rollout gets first hits a snag from Covid gives during Covid up restrictions staff diagnosed (which only needs Macy’s is flying Pfizer slows sharply large-scale rollout US Hospitals under COVID-19 vaccines vaccine for US Jan. 11, 2021 approval for into “Tier Four” Dec. 23, 2020 in the US since the AstraZeneca vaccine AstraZeneca jab similar level of ahead of with COVID-19 to be refrigerated Thanksgiving Day COVID-19 vaccine as pandemic takes of coronavirus “extreme stress” Jan. 6, 2021 Dec. 19, 2020 lockdown coronavirus In US, Oklahoma’s protection to vaccine Oklahoma Events Thanksgiving - not frozen, like Parade marches on! 1st virus vaccine toll on economy vaccines and “overloaded” Jan. 1, 2021 Jan. 9, 2021 Jan. 18, 2021 Thailand grapples pandemic began Vaccine refusers scheduling portal Pfizer and Moderna) Dec. 13, 2020 Dec. 16, 2020 How many COVID-19 Dec. 30, 2020 Jan. 4, 2021 with virus outbreak may be limited Queen launches Israel trades Pfizer Economic News found to be 70-90% vaccines has each Demand for Jan. 15, 2021 Nov. 29, 2020 Dec. 2, 2020 Dec. 5, 2020 Canada secures Dec. 21, 2020 1st US case of virus Britain's jab blitz doses for effective Nov. 26, 2020 Dec. 10, 2020 Historic U.S. COVID country bought? rescue animals US vaccine Jan. 12, 2021 vaccine campaign early doses from Dec. 27, 2020 variant detected has skyrocketed administation Tracking US medical data Pandemic The 5 US states Moscow opens US Congress Dec. 23, 2020 Jan. 7, 2021 Hospitalizations launches with Moderna in Colorado tracker Irish infection rate COVID vaccine calls off Christmas with the most dozens of Sweden pulls a seals agreement “Hug booth” allows Jan. 10, 2021 in the US convoy of trucks US reports highest “world’s highest” distribution by state markets in Europe hospitalizations coronavirus U-turn and proposes on $900 billion US buys more doses nursing home hit another record Jan. 2, 2021 single-day death toll vaccination centers a lockdown law COVID relief bill of Pfizer vaccine residents to touch Johnson under fire as UK again faces Dec. 2, 2020 Dec. 13, 2020 their loved ones Jan. 12, 2021 Israel leads vaccine onslaught of Jan. 16, 2021 race with 12% Dec. 24, 2020 COVID-19 US reports its COVID-19 vaccine given jab Potential super China has suffered highest one-day in Oklahoma: spreader event a surge of cases death tally: Who gets it first? Santa Claus since December Overview: Over 2,800 is “good to go!” Year 1 of COVID Jan.Jan. 22,7, 2021 2021 Jan.Jan. 29,7, 2021 2021 Feb. 5, 2021 Feb. 13, 2021 Feb. 24, 2021 Mar. 7, 2021 Mar. 18, 2021 Mar. 29, 2021 Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths over 1,900,0002,100,000 over 1,900,0002,200,000 over 2,300,000 over 2,400,000 over 2,500,000 over 2,600,000 over 2,700,000 over 2,800,000 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 Jan. 19, 2021 Jan. 22, 2021 Jan. 25, 2021 Jan. 28, 2021 Jan. 31, 2021 Feb. 2, 2021 Feb. 5, 2021 Feb. 7, 2021 Feb. 10, 2021 Feb. 13, 2021 Feb. 16, 2021 Feb. 17,19, 2021 Feb. 17,22, 2021 Feb. 17,25, 2021 Feb. 17,27, 2021 Feb.Mar. 17,2, 2021 2021 Feb.Mar. 17,5, 2021 2021 Feb.Mar. 17,8, 2021 2021 Feb.Mar. 17,11, 2021 Feb.Mar. 14,17, 2021 Feb.Mar. 16,17, 2021 Feb.Mar. 19,17, 2021 Feb.Mar. 22,17, 2021 Feb.Mar. 25,17, 2021 Feb.Mar. 28,17, 2021 A new COVID-19 Lucky few hit Bernie happy his How is the COVID-19 US hospitalizations Israel's vaccine Johnson &Johnson Richer countries The US needs more Should you mix and India’s dramatic fall How the US states US death toll Comparing the Diagram of the Chinese vaccines Countries making FDA issues EUA Israel’s cases drop AstraZeneca’s EU Flashcards for Uptick of infections AstraZeneca vaccine Scientists mull clues “VIPIT” syndrome challenge: Mutations vaccine jackpot memes may raise vaccination campaign and ICU numbers rollout linked to seeks vaccine stockpile vaccines; viral sequencing match COVID-19 of cases leaves rank for safety nears 500,000 Spanish Flu to many mutations sweep much of dubious claims over for T-cell test after lockdown exit vaccine woes the main vaccines in 15 US states safe and effective on virus’ origin associated with rise along with cases for rare extra doses money for charity going in your state? are dropping infection fall clearance with FDA Africa is being How is your vaccines? experts stumped during COVID the COVID pandemic the world Covid-19 cases in new trial data AztraZeneca vaccine left behind state doing? Feb.Mar. 16,17, 2021 Feb.Mar. 19,17, 2021 Feb. 17,22, 2021 Feb. 17,28, 2021 Feb.Mar. 17,9, 2021 2021 Feb.Mar. 17,11, 2021 Feb.Mar. 14,17, 2021 Feb.Mar. 26,17, 2021 Jan. 31, 2021 Feb. 2, 2021 Feb. 5, 2021 Feb. 14, 2021 Feb.Mar. 23,17, 2021 Jan. 20, 2021 Jan. 22, 2021 Jan. 25, 2021 Jan. 28, 2021 Feb. 16, 2021 Feb. 17,20, 2021 Feb. 17,25, 2021 Feb.Mar. 17,3, 2021 2021 Feb.Mar. 17,5, 2021 2021 Signs the pandemic Feb.Mar. 29,17, 2021 Feb. 7, 2021 South African UK Study: Novavax UK variant detected Thai PM gets Two emerging Feb.
Load more

Recommended publications
  • June 11, 2021 the Honorable Xavier Becerra Secretary Department of Health and Human Services 200 Independence Ave S.W. Washingto
    June 11, 2021 The Honorable Xavier Becerra Secretary Department of Health and Human Services 200 Independence Ave S.W. Washington, D.C. 20201 The Honorable Francis Collins, M.D., Ph.D. Director National Institutes of Health 9000 Rockville Pike Rockville, MD 20892 Dear Secretary Becerra and Director Collins, Pursuant to 5 U.S.C. § 2954 we, as members of the United States Senate Committee on Homeland Security and Governmental Affairs, write to request documents regarding the National Institutes of Health’s (NIH) handling of the COVID-19 pandemic. The recent release of approximately 4,000 pages of NIH email communications and other documents from early 2020 has raised serious questions about NIH’s handling of COVID-19. Between June 1and June 4, 2021, the news media and public interest groups released approximately 4,000 pages of NIH emails and other documents these organizations received pursuant to Freedom of Information Act requests.1 These documents, though heavily redacted, have shed new light on NIH’s awareness of the virus’ origins in the early stages of the COVID- 19 pandemic. In a January 9, 2020 email, Dr. David Morens, Senior Scientific Advisor to Dr. Fauci, emailed Dr. Peter Daszak, President of EcoHealth Alliance, asking for “any inside info on this new coronavirus that isn’t yet in the public domain[.]”2 In a January 27, 2020 reply, Dr. Daszak emailed Dr. Morens, with the subject line: “Wuhan novel coronavirus – NIAID’s role in bat-origin Covs” and stated: 1 See Damian Paletta and Yasmeen Abutaleb, Anthony Fauci’s pandemic emails:
    [Show full text]
  • Melissaossmanpro.Pdf
    August 19, 2021 Chairman Lipps, Vice Chair Holmes, Ranking Member Russo, and Members of the House Health Committee, thank you for the opportunity to provide proponent testimony on House Bill 248. My family and I are asking that Ohio HB248 be passed in order to protect the individual freedoms we currently have as American citizens. I work in a corporate setting and my husband owns a small business. We have two young daughters who are relying on us to provide for them and protect their rights. I support this bill in hopes that they can grow up with the same liberties we have had. Segregation and discrimination over individual health choices should be taken seriously and passing this bill is key to avoiding those types of issues in the future. I am not a scientist, but I am a mom, a wife, and a daughter who takes the health of my family very seriously. I have done extensive amounts of research on the SARS-COV2 virus and subsequent vaccines. There are also many health experts that provide me with helpful information. I am sure you are receiving many testimonies about the large numbers of vaccine injuries and even deaths that have occurred during this vaccine campaign. Personally, I know two women who have had severe menstrual issues (requiring surgery) that they can connect back to occurring right after the vaccine. My friends’ cousin passed away at only 23 years old from an enlarged heart after receiving the vaccine. The stories go on and on. The point is that no legislation should force my family and I to inject ourselves with substances that have side effects such as this.
    [Show full text]
  • The Highly Pathogenic Avian Influenza A(H5N1) Virus: a Twenty-Year Journey of Narratives and (In)Secure Landscapes
    The Highly Pathogenic Avian Influenza A(H5N1) Virus: a twenty-year journey of narratives and (in)secure landscapes Philip Rolly Egert Dissertation submitted to the faculty of the Virginia Polytechnic Institute and State University in partial fulfillment of the requirements for the degree of Doctor of Philosophy In Science, Technology, and Society Barbara L. Allen (Chair) Daniel Breslau Bernice L. Hausman David C. Tomblin March 18, 2016 Falls Church, Virginia Keywords: H5N1, HPAI, highly pathogenic avian influenza virus, pandemic, social justice, bioterrorism, bioethics, biopower, tacit knowledge, dual-use dilemma, dual-use research of concern, emerging infectious disease Copyright Philip R. Egert The Highly Pathogenic Avian Influenza A(H5N1) Virus: a twenty-year journey of narratives and (in)secure landscapes Philip Rolly Egert ABSTRACT This dissertation is comprised of two manuscripts that explore various contestations and representations of knowledge about the highly pathogenic avian influenza H5N1virus. In the first manuscript, I explore three narratives that have been produced to describe the 20-year journey of the virus. The journey begins in 1996 when the virus was a singular localized animal virus but then over the next 20 years multiplied its ontological status through a (de)stabilized global network of science and politics that promoted both fears of contagion and politics of otherness. Written by and for powerful actors and institutions in the global North, the narratives focused on technical solutions and outbreak fears. In doing so, the narratives produced policies and practices of biopower that obscured alternative considerations for equity, social justice, and wellbeing for the marginalized groups most directly affected by the H5N1 virus.
    [Show full text]
  • Emerging Leaders in Biosecurity Initiative
    Emerging Leaders in Biosecurity Initiative Class of 2017 A competitive fellowship program created to identify, develop, and provide networking opportunities Yearbook for the next generation of leaders in biosecurity. Emerging Leaders in Biosecurity Initiative Contents Letter: 3 Thomas V. Inglesby, Director; Anita Cicero, Deputy Director, Johns Hopkins Center for Health Security Executive Steering Committee 5 Class of 2017 Fellows 9-35 ELBI 2017 Year in Review 36-37 ELBI Program Staff 41 ELBI Alumni 42 Cover and Inside Cover Photo Overlay: Swine Flu Strain Virus Particles. Col- orized transmission electron micrograph of negatively stained SW31 (swine strain) influenza virus particles. Credit: NIAID Emerging Leaders in Biosecurity Initiative The ELBI Fellowship program is made possible through financial support from the Open Philanthropy Project, under management by the Johns Hopkins Center for Health Security, and with the leadership of the ELBI Executive Steering Committee. For more information, please visit the ELBI website: http://www.centerforhealthsecurity.org/our-work/emergingbioleaders Center for Health Security “Modern conditions make the scenario of a global pandemic more likely. Humans are encroaching on animal environments, raising chances for pathogens to adapt from animals to people. An increasing share of the planet lives in megacities, heightening the likelihood of person-to-person transmission of pathogens. The movement of people and microbes around the globe is more efficient than ever. The recent outbreaks of SARS, MERS, and Ebola are only small glimpses of how quickly a deadly virus can spread.” Tom Inglesby and Benjamin Haas Foreign Affairs November 21, 2017 Middle East Respiratory Syndrome Coronavirus particle envelope proteins immunolabeled with Rabbit HCoV-EMC/2012 primary antibody and Goat an- 1 ti-Rabbit 10 nm gold particles.
    [Show full text]
  • SYRA MADAD, D.H.Sc, M.Sc., MCP
    SYRA MADAD, D.H.Sc, M.Sc., MCP Syra Madad, D.H.Sc., M.Sc., MCP is nationally recognized leader in public health and special pathogen preparedness and response. She is Senior Director, System-wide Special Pathogens Program at New York City Health + Hospitals, the nation’s largest municipal healthcare delivery system overseeing special pathogen preparedness and response efforts across 11 acute care hospitals in addition to post-acute/long-term care facilities and ambulatory care sites. She is Principal Investigator of NYC Health + Hospitals Center for Global Healthcare Preparedness to Special Pathogens. In addition, Dr. Madad is Core Faculty in the National Ebola Training and Education Center (NETEC), funded by the Centers for Disease Control and Prevention (CDC) and the Assistant Secretary for Preparedness and Response (ASPR) and Assistant Professor in the Graduate Biotechnology/Biodefense Program at the University of Maryland. She is an Alumni Fellow at Johns Hopkins Bloomberg School of Public Health, Center for Health Security’s Emerging Leaders in Biosecurity Program and the Federal Bureau of Investigation’s Behavioral Informatics & Technological Enterprise Studies Program. Dr. Madad earned her Doctoral degree in Health Science with a concentration in Global Health from Nova Southeastern University, graduating with Alpha Eta Health Science Honor Society status. She obtained her Master of Science degree in Biotechnology with a concentration in Biodefense and Biosecurity and Bachelor of Science degree in Psychology from the University of Maryland. Dr. Madad holds numerous professional certifications, licenses and training certificates including Master Continuity Practitioner Certification (FEMA), Advanced Emergency Planning Certification, All Hazard Response (CBRNE) Training for Laboratory Personnel, Biosafety Level III Training, and Identification of the Primary Select Agents of Bioterrorism Training.
    [Show full text]
  • Medical JOUR
    RHODE ISLAND M EDiCAL J ournal ZOOM – It’s a Match! Virtual National Match Day is largest on record See page 75 R SPECIAL SECTION, PART II BIOMEDICAL/TRANSLATIONAL RESEARCH in RI GUEST EDITORS: JAMES PADBURY, MD; BONGSUP CHO, PhD ApRiL 2021 VOLUME 104 • NUMBER 3 iSSN 2327-2228 REINVENTING WHAT YOU EXPECT FROM A MEDICAL PROFESSIONAL LIABILITY PROVIDER. With Coverys, you can reduce the distractions that come between diagnosis and outcomes. By leveraging claims data and analytics plus innovative educational resources, we’re helping doctors and administrators reduce distractions and focus on improving clinical, operational, and financial outcomes.Visit coverys.com Insurance products issued by ProSelect® Insurance Company (NE, NAIC 10638) and Preferred Professional Insurance Company® (NE, NAIC 36234). RHODE ISLAND M EDICAL J OURNAL 15 Translational Research: The Time is Now JAMES F. PADBURY, MD BONGSUP P. CHO, PhD GUEST EDITORS James F. Padbury, MD Bongsup Cho, PhD 17 The Time is NOW: Filling the Gaps in Treatment of Opioid-Exposed Infants: A Prospective, Pragmatic, Randomized Control Drug Trial ADAM J. CZYNSKI, DO; ABBOT R. LAPTOOK, MD 22 COBRE on Opioid and Overdose: A Collaborative Research-Based Center Addressing the Crises in Rhode Island and Beyond TRACI C. GREEN, PhD, MSc; ELIANA KAPLOWITZ, BA; KIRSTEN LANGDON, PhD; JACLYN M.W. HUGHTO, PhD, MPH; WILLIAM C. GOEDEL, PhD; ADAM J. CZYNSKI, DO; GAYLE FRASER, BS; JOSIAH RICH, MD, MPH 27 Brown University COBRE Center for Addiction and Disease Risk Exacerbation PETER M. MONTI, PhD; JENNIFER W. TIDEY, PhD; JASJIT S. AHLUWALIA, MD 32 The Center of Biomedical Research Excellence (COBRE) for Perinatal Biology – Accomplishments, Impact, and Long-term Results SUNIL K.
    [Show full text]
  • Clinical Laboratory Preparedness and Response Guide
    TABLE OF CONTENTS Table of Contents ...................................................................................................................................................................................... 2 State Information ....................................................................................................................................................................................... 7 Introduction .............................................................................................................................................................................................. 10 Laboratory Response Network (LRN) .......................................................................................................................................... 15 Other Emergency Preparedness Response Information: .................................................................................................... 19 Radiological Threats ......................................................................................................................................................................... 21 Food Safety Threats .......................................................................................................................................................................... 25 BioWatch Program ............................................................................................................................................................................ 27 Bio Detection Systems
    [Show full text]
  • Peter Daszak IPBES Scoping for the Nexus Assessment: Health
    IPBES Scoping for the Nexus Assessment: Health & Linkages Peter Daszak [email protected] The focus for this session Three thematic areas: 1. Biodiversity & health 2. Global environmental change & health 3. Food, water & health Your suggestions on: • Scope of the assessment • Questions to address Post-2020 Biodiversity Framework and Global Goals . Aichi Biodiversity Targets, particularly: • Target 14. Biodiversity and Ecosystem Services . Sustainable Development Goals, e.g.: • 3. Health; • 6. Clean Water and Sanitation; • 13. Climate Action; • 14. Aquatic Ecosystems; • 15. Terrestrial Ecosystems; • 17. Partnerships . Global Health Security Agenda (Prevent, Detect, Respond) . Sendai Framework for Disaster Risk Reduction 2015-2030 • Bangkok Principles for implementation of health aspects One Health approach • Health of people, wildlife, livestock, environment • Impact of human-mediated global environmental change on health across all sectors Biodiversity’s Health Services Pharmaceuticals • Penicillin (fungus); Digitalis (foxglove plant); Quinine and quinidine (Peruvian Cinchona tree); Morphine and codeine (poppies); Taxol (Pacific Yew tree) Welfare • Link between good mental health and open spaces, biodiversity, forests/parks • Outdoor activity linked to overall fitness and lack of disease • Dietary diversity and nutritional health Protection against disease • Lower risk emerging diseases from undisturbed intact forest Honey Bee Declines in U.S.A. Biodiversity loss & health Intact Forest Residential Urban Culex mosquitoes prefer
    [Show full text]
  • ISSUE #9 from the Red Patriot Show Some Articles May Require Subscriptions
    J E u l y H 1 T 4 The News t Red R eport h The People • The Right Way , ' 2 1 ISSUE #9 from The Red Patriot Show Some articles may require subscriptions CHINESE-MADE COVID-19 VACCINE RECIPIENTS WON’T COUNT AS VACCINATED: SINGAPORE The Epoch Times Singapore’s health agency said that individuals who have received the Chinese-made COVID-19 vaccine won’t count as being vaccinated. BIDEN ADMIN TO GO “The national vaccination numbers reflect only those vaccinated under the national vaccination program,” the country’s Ministry of ‘DOOR-TO-DOOR’ TO Health said on Tuesday. “Currently, this only includes those vaccinated VACCINATE PEOPLE with the Moderna COVID-19 and Pfizer-BioNTech/Comirnaty vaccines.” America's C itizen Press COVID-19 is the disease caused by the CCP (Chinese Communist Party) virus, otherwise known as the coronavirus. President Joe Biden’s administration plans to go door-to-door to vaccinate people against COVID-19. The city-state’s health officials said there is inadequate efficacy data for “Now we need to go to community-by-community, neighborhood- the Sinovac COVID-19 vaccine, namely against the Delta strain. The by-neighborhood, and oft-times door-to-door, literally knocking variant has become the most prevalent COVID-19 strain in the country. on doors,” said Biden. Watch Biden threaten to send government officials to your door to make you take an OPTIONAL vaccine. WATCH BIDEN While answering a question, Biden appeared to lose his train STRUGGLE TO of thought and completely SPEAK YET forget the name Osama Bin Laden for about five to six AGAIN seconds.
    [Show full text]
  • Legal-Graphics' 6-26-21 COVID Timeline
    Number of days since first sign of virus Overview: Year 2 of COVID Year 2 Nov. 23, 2020 Dec. 3, 2020 Dec. 11, 2020 Dec. 21, 2020 Dec. 30, 2020 Jan. 7, 2021 Jan.Jan. 14,7, 2021 2021 of COVID-19 Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Worldwide Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths Coronavirus Deaths over 1,400,000 over 1,500,000 over 1,600,000 over 1,700,000 over 1,800,000 over 1,900,000 over 1,900,0002,000,000 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 Link to Nov. 16, 2020 Nov. 18, 2020 Nov. 21, 2020 Nov. 25, 2020 Nov. 27, 2020 Nov. 30, 2020 Dec. 3, 2020 Dec. 6, 2020 Dec. 8, 2020 Dec. 11, 2020 Dec. 14, 2020 Dec. 17, 2020 Dec. 21, 2020 Dec. 22, 2020 Dec. 26, 2020 Dec. 29, 2020 Dec. 31, 2020 Jan. 3, 2021 Jan. 5, 2021 Jan. 8, 2021 Jan. 11, 2021 Jan. 13, 2021 Jan. 17, 2021 Source Moderna says data FDA allows US cases top Picture of US Demand for live Moderna to request Map showing US UK gears up for Chart of cumulative Pfizer vaccine to be How do the Pfizer Vaccinations reach How the Pfizer Vaccines across Could AZD7442 Map showing How vaccinations Interactive US Map It’s lockdown No.
    [Show full text]
  • Lessons from COVID-19 to Help Prevent Future Pandemics
    China CDC Weekly Commentary Lessons from COVID-19 to Help Prevent Future Pandemics Peter Daszak# In just over 12 months since it was first discovered, that allow diseases like COVID-19 to spread globally coronavirus disease 2019 (COVID-19) has caused over within days or weeks (4). Understanding these 100 million confirmed cases and more than 2.2 million patterns, provides the elements of a prevention deaths. Its impact on our global economy has been strategy. staggering and likely to be in the tens of trillions of The first step in any battle is to know your enemy, dollars by the time vaccines are fully deployed (1). and in this case identify the size of the threat and COVID-19 has caused significant hardship, mortality, where it’s coming from. Given that viruses are the and morbidity across the world, from the lockdowns predominant group of pathogens and that most viral experienced by the citizens of Wuhan in early 2020, zoonoses are acquired from mammalian hosts, we through to the waves of case spikes in European, North repeatedly sampled two species of mammals (a fruit bat American, and other countries. Pandemics of this scale and primate) and conducted the same viral discovery are rare, and many have called COVID-19 a once-in-a- protocol on each sample. Using data on the rate of century pandemic, but our research suggests that they discovery of new strains compared to repeat findings, are increasing in frequency, driven by a rise in the we were able to estimate the unknown diversity of animal-to-human pathogen spillover events that viruses in all mammal species — around 1.6 million usually cause them (2).
    [Show full text]
  • Framework for Equitable Allocation of COVID-19 Vaccine (2020)
    THE NATIONAL ACADEMIES PRESS This PDF is available at http://nap.edu/25917 SHARE Framework for Equitable Allocation of COVID-19 Vaccine (2020) DETAILS 260 pages | 6 x 9 | PAPERBACK ISBN 978-0-309-68224-4 | DOI 10.17226/25917 CONTRIBUTORS GET THIS BOOK Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors; Committee on Equitable Allocation of Vaccine for the Novel Coronavirus; Board on Health Sciences Policy; Board on Population Health and Public Health Practice; Health FIND RELATED TITLES and Medicine Division; National Academies of Sciences, Engineering, and Medicine; National Academy of Medicine SUGGESTED CITATION National Academies of Sciences, Engineering, and Medicine 2020. Framework for Equitable Allocation of COVID-19 Vaccine. Washington, DC: The National Academies Press. https://doi.org/10.17226/25917. Visit the National Academies Press at NAP.edu and login or register to get: – Access to free PDF downloads of thousands of scientific reports – 10% off the price of print titles – Email or social media notifications of new titles related to your interests – Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. (Request Permission) Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Copyright © National Academy of Sciences. All rights reserved. Framework for Equitable Allocation of COVID-19 Vaccine Framework for Equitable Allocation of COVID-19 Vaccine Helene Gayle, William Foege, Lisa Brown, and Benjamin Kahn, Editors Committee on Equitable Allocation of Vaccine for the Novel Coronavirus Board on Health Sciences Policy Board on Population Health and Public Health Practice Health and Medicine Division PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright National Academy of Sciences.
    [Show full text]